Tradestie Institutional Equity Comparison Engine

INCY vs VRTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VRTX Overall Edge

VRTX Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vertex Pharmaceuticals Inc (VRTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, INCY trades at 14.0x Forward P/E with 32.2% operating margin (+14.0% YoY revenue) versus VRTX at 27.0x Forward P/E and 37.8% operating margin (+11.8% YoY). In options structure, INCY sits in CONSOLIDATION (64th %ile IV; Dealer Gamma Walls on Pro) against VRTX sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VRTX
INCY 14.0x vs VRTX 27.0x Fwd P/E
Growth & Margin Winner VRTX
Op Margin 32.2% vs 37.8% ยท YoY +14.0% vs +11.8%
Momentum & Technical Winner VRTX
1Y +13.7% vs +23.2% ยท 52W Pos 71% vs 79%
Options & Structure Winner VRTX
CONSOLIDATION (64th %ile IV) vs CONSOLIDATION (25th %ile IV)
INCY NASDAQ
Incyte Genomics Inc
Services-Commercial Physical & Biological Research
$119.86
-0.92% 1D
Market Cap $24.8B
1M Return +6.01%
1Y Return +13.71%
Forward P/E 14.0x
Unified AI Score
61.2 / 100 BUY
Tech 45.0 Fund 56.0 Flow 68.0 Mom 60.0
VRTX NASDAQ
Vertex Pharmaceuticals Inc
Pharmaceutical Preparations
$535.27
-0.62% 1D
Market Cap $137.6B
1M Return +7.11%
1Y Return +23.19%
Forward P/E 27.0x
Unified AI Score
37.0 / 100 SELL
Tech 39.0 Fund 48.0 Flow 70.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INCY +13.71% VRTX +23.19% Spread: +9.48 pp (VRTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period INCY Revenue VRTX Revenue INCY Op. Margin VRTX Op. Margin Margin Edge
FY2018 $1.88B $3.05B 6.9% 20.8% VRTX
FY2019 $2.16B $4.16B 18.6% 28.8% VRTX
FY2020 $2.67B $6.21B -9.9% 46.0% VRTX
FY2021 $2.99B $7.57B 19.6% 36.7% VRTX
FY2022 $3.39B $8.93B 17.1% 48.2% VRTX
FY2023 $3.70B $9.87B 16.8% 38.8% VRTX
FY2024 $4.24B $11.0B 1.4% -2.1% INCY
FY2025 $5.14B $12.0B 29.5% 34.8% VRTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INCY (3) vs VRTX (7)
Institutional Metric INCY VRTX Criterion Row Winner
Market Capitalization Scale $24.8B $137.6B Larger Scale VRTX
Trailing P/E Ratio Valuation 62.1x 34.9x Lower Multiple VRTX
Forward P/E Ratio Valuation 14.0x 27.0x Lower Multiple INCY
Revenue Growth (YoY) Growth +14.0% +11.8% Higher Growth INCY
Operating Margin (TTM) Profitability 32.2% 37.8% Higher Margin VRTX
Net Profit Margin Profitability 6.7% 30.7% Higher Margin VRTX
Return on Equity (ROE) Capital Efficiency 7.8% 20.8% Higher ROE VRTX
52-Week Range Position Momentum 71% ($89โ€“$133) 79% ($412โ€“$569) Stronger Trend VRTX
Beta / 30D Volatility Risk Regime 0.30ฮฒ ยท 35% Vol 0.36ฮฒ ยท 30% Vol Lower Realized Risk VRTX
Unified Institutional Score Composite Signal 61.2 / 100 (BUY) 37.0 / 100 (SELL) Higher Composite INCY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INCY vs VRTX Buy Guide
INCY CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 64th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live INCY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VRTX CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VRTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INCY nor VRTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.